Author:
Wen Shu Fen,Mahavni Vikas,Quijano Erlinda,Shinoda Jeremy,Grace Michael,Musco-Hobkinson Mary Lynn,Yang Tong-Yuan,Chen Yuetian,Runnenbaum Ingo,Horowitz JoAnn,Maneval Dan,Hutchins Beth,Buller Richard
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference36 articles.
1. Dummer R, Bergh J, Karlsson Y, et al. Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors. Cancer Gene Ther. 2000;7:1069–1076.
2. Schuler M, Rochlitz C, Horowitz JA, et al. A phase I study of adenovirus mediated wild type p53 gene therapy in patients with advanced non-small cell lung cancer. Hum Gene Ther. 1998;15:1750–1758.
3. Schuler M, Herrmann R, De Greve JL, et al. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multi-center phase II study. J Clin Oncol. 2001;19:1750–1758.
4. Kuball J, Wen SF, Leissner J, et al. Successful adenovirus –mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation. J Clin Oncol. 2002;20:957–965.
5. Ring E, Nonaka-Wong S, Horowitz JA, et al. Gene therapy of colorectal liver metastases using a recombinant adenovirus encoding wt p53 (SCH 58500) via hepatic artery infusion: a phase I study. Abstract. ASCO, 1998.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献